Insights

Gathering insights about CRY…

Similar companies to CRY

CRY Tech Stack

CRY uses 8 technology products and services including Hotjar, Section.io, Squarespace, and more. Explore CRY's tech stack below.

Hotjar
Analytics
Section.io
Content Delivery Network
Squarespace
Content Management System
Webpack
Development
Google Fonts API
Font Scripts
Font Awesome
Font Scripts
Modernizr
Javascript Libraries
Google Analytics
Web Analytics

Media & News

Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript
Artivion, Inc. (NYSE:AORT ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Eileen Martin - Investor Relations Pat Mackin - Chief Executive Officer Lance Berry - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Suraj Kalia - Oppenheimer John McAulay - Stifel Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. And welcome to Artivion's Second Quarter 2024 Financial Conference Call.
Aug 10, 2024 | seekingalpha.com
Artivion (AORT) Surpasses Q2 Earnings and Revenue Estimates
Artivion (AORT) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.06 per share a year ago.
Aug 08, 2024 | www.zacks.com
Artivion Reports Second Quarter 2024 Financial Results
Second Quarter Highlights: Achieved revenue of $98.0 million in the second quarter of 2024 versus $89.3 million in the second quarter of 2023, an increase of 10% on both a GAAP and constant currency basis Net loss was ($2.1) million or ($0.05) per fully diluted share and non-GAAP net income was $2.9 million or $0.07 per fully diluted share in the second quarter of 2024 Adjusted EBITDA increased 35% to $18.6 million in the second quarter of 2024 compared to $13.8 million in the second quarter of 2023 Raised FY24 revenue guidance to 10% to 12% year-over-year growth on a constant currency basis, an increase of 0.5% at the midpoint Raised FY24 adjusted EBITDA guidance to 28% to 34% year-over-year growth, an increase of 1% at the midpoint ATLANTA , Aug. 8, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the second quarter ended June 30, 2024. "In the second quarter, we continued to make substantial progress on our strategic growth initiatives to drive sustained and profitable growth, and we further solidified our position as the leader in the aortic disease space.
Aug 08, 2024 | www.prnewswire.com
Artivion to Participate in Upcoming Investor Conferences
ATLANTA , Aug. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion's management team will present at the upcoming Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, 2024 at the InterContinental Boston Hotel.
Aug 05, 2024 | www.prnewswire.com
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
ATLANTA , July 25, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2024 financial results will be released on Thursday, August 8, 2024 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.
Jul 25, 2024 | www.prnewswire.com
Artivion Amends Agreements with Endospan
Provides Endospan with $25 million of Additional Debt Funding to Obtain FDA Approval for NEXUS Upfront Payment Associated with Purchase Option Reduced to $135 million, inclusive of loan off-set, and $100 million earnout minimum eliminated ATLANTA , July 1, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced it has amended its credit facility and option purchase agreements with Endospan Ltd. ("Endospan"), an Israeli-based, privately-held developer of the NEXUS® Stent Graft System ("NEXUS").
Jul 01, 2024 | www.prnewswire.com
Data-Driven Growth Fuels More Upside For Overlooked Artivion
Artivion, Inc. has continued to log double-digit revenue growth with contributions from diverse assets including its stent grafts, heart valves, and cryopreserved tissue grafts. Positive post-approval trial data for the On-X aortic valve and a successful PERSEVERE IDE study for AMDS hybrid prosthesis can drive additional revenue growth. A strong pipeline, including NEXUS and ARCEVO stent graft systems, can support a longer runway of continued revenue growth.
Jun 21, 2024 | seekingalpha.com

CRY's Email Address Formats

CRY uses at least 2 format(s):

CRY Email Formats	Example	Percentage
FLast@abandonfilms.com	JDoe@abandonfilms.com	67%
First@abandonfilms.com	John@abandonfilms.com	33%
First@filmcry.com	John@filmcry.com	100%

Frequently Asked Questions

Where is CRY's headquarters located?

CRY's main headquarters is located at 1314 Jefferson Street, Lynchburg, Virginia 24504, US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is CRY's phone number?

You can contact CRY's main corporate office by phone at

+1-540-904-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is CRY's stock symbol?

CRY is a publicly traded company; the company's stock symbol is CRY.

What is CRY's official website and social media links?

CRY's official website is filmcry.com and has social profiles on LinkedIn.

What is CRY's NAICS code?

CRY's NAICS code is 51211 - Motion Picture and Video Production.

How many employees does CRY have currently?

As of October 2025, CRY has approximately 11 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Cofounder / Director: J. R.Executive Producer And Head Of Business Development: C. V.Creative Director: J. S.. Explore CRY's employee directory with LeadIQ.

What industry does CRY belong to?

CRY operates in the Media Production industry.

What technology does CRY use?

CRY's tech stack includes HotjarSection.ioSquarespaceWebpackGoogle Fonts APIFont AwesomeModernizrGoogle Analytics.

What is CRY's email format?

CRY's email format typically follows the pattern of FLast@abandonfilms.com. Find more CRY email formats with LeadIQ.

When was CRY founded?

CRY was founded in 2007.

CRY

Q: What is CRY's official website and social media links?

CRY's official website is filmcry.com. CRY has social profiles on LinkedIn.

Q: How many employees does CRY have currently?

CRY has approximately 11 employees.

Q: What technology does CRY use?

CRY's tech stack includes Google Fonts API, Google Analytics, Hotjar, Webpack, Modernizr.

Media ProductionUnited States11-50 Employees

Cry is an independent, full-service creative production house that works with clients who want to incorporate creative collaboration to make incredible video advertising, brand content, and films.

At Cry we create compelling visual narratives for clients and their audiences by delivering agile thought leadership and breakthrough creative.
 
We believe that most brands have not fully explored the possibilities of their narrative, and we are in the business of elevating brands to entirely new levels through visual storytelling. 
 
Services include video advertising / commercial filmmaking, long and short form video, and brand strategy.